Suppr超能文献

相似文献

1
Iontophoretic transport of charged macromolecules across human sclera.
Int J Pharm. 2010 Mar 30;388(1-2):107-13. doi: 10.1016/j.ijpharm.2009.12.046. Epub 2010 Jan 5.
2
Enhanced transscleral lontophoretic transport with ion-exchange membrane.
Pharm Res. 2006 Aug;23(8):1857-67. doi: 10.1007/s11095-006-9010-9.
3
Transscleral passive and iontophoretic transport: theory and analysis.
Expert Opin Drug Deliv. 2018 Mar;15(3):283-299. doi: 10.1080/17425247.2018.1406918. Epub 2017 Dec 5.
5
Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules.
J Ocul Pharmacol Ther. 2020 May;36(4):247-256. doi: 10.1089/jop.2019.0081. Epub 2020 Mar 5.
8
In-vitro permeation of bevacizumab through human sclera: effect of iontophoresis application.
J Pharm Pharmacol. 2010 Sep;62(9):1189-94. doi: 10.1111/j.2042-7158.2010.01153.x.
9
Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.
J Pharm Sci. 2013 Mar;102(3):892-903. doi: 10.1002/jps.23387. Epub 2012 Dec 4.
10
In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Eur J Pharm Biopharm. 2014 Sep;88(1):116-22. doi: 10.1016/j.ejpb.2014.04.018. Epub 2014 May 9.

引用本文的文献

2
Pulsed Ultrasound-Mediated Drug Delivery Enhancement Through Human Sclera.
Transl Vis Sci Technol. 2025 Jan 2;14(1):7. doi: 10.1167/tvst.14.1.7.
3
Sustained release of RNA nanoparticles from reservoir implant for ocular delivery.
J Pharm Sci. 2025 Feb;114(2):1423-1433. doi: 10.1016/j.xphs.2024.12.019. Epub 2024 Dec 24.
4
Advances in ophthalmic therapeutic delivery: A comprehensive overview of present and future directions.
Surv Ophthalmol. 2024 Nov-Dec;69(6):967-983. doi: 10.1016/j.survophthal.2024.07.002. Epub 2024 Jul 8.
5
Posterior eye delivery of angiogenesis-inhibiting RNA nanoparticles via subconjunctival injection.
Int J Pharm. 2024 May 25;657:124151. doi: 10.1016/j.ijpharm.2024.124151. Epub 2024 Apr 23.
6
Application of iontophoresis in ophthalmic practice: an innovative strategy to deliver drugs into the eye.
Drug Deliv. 2023 Dec;30(1):2165736. doi: 10.1080/10717544.2023.2165736.
7
A Highly Efficacious Electrical Biofilm Treatment System for Combating Chronic Wound Bacterial Infections.
Adv Mater. 2023 Feb;35(6):e2208069. doi: 10.1002/adma.202208069. Epub 2022 Dec 20.

本文引用的文献

1
In vitro transscleral iontophoresis of high molecular weight neutral compounds.
Eur J Pharm Sci. 2009 Mar 2;36(4-5):486-92. doi: 10.1016/j.ejps.2008.11.012. Epub 2008 Dec 6.
2
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans.
Am J Ophthalmol. 2008 Oct;146(4):508-12. doi: 10.1016/j.ajo.2008.05.036. Epub 2008 Jul 17.
3
Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis.
J Ocul Pharmacol Ther. 2008 Jun;24(3):344-50. doi: 10.1089/jop.2007.0097.
4
In vitro and in vivo evaluation of carboplatin delivery to the eye using hydrogel-iontophoresis.
Curr Eye Res. 2008 Mar;33(3):269-75. doi: 10.1080/02713680701871140.
5
Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
Curr Eye Res. 2007 Jul-Aug;32(7-8):639-46. doi: 10.1080/02713680701528674.
7
Challenges and obstacles of ocular pharmacokinetics and drug delivery.
Adv Drug Deliv Rev. 2006 Nov 15;58(11):1131-5. doi: 10.1016/j.addr.2006.07.027. Epub 2006 Sep 26.
8
Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
Adv Drug Deliv Rev. 2006 Nov 15;58(11):1164-81. doi: 10.1016/j.addr.2006.07.025. Epub 2006 Sep 16.
9
Iontophoresis: a non-invasive ocular drug delivery.
J Control Release. 2006 Feb 21;110(3):479-89. doi: 10.1016/j.jconrel.2005.09.049. Epub 2005 Dec 15.
10
Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Adv Drug Deliv Rev. 2005 Dec 13;57(14):2063-79. doi: 10.1016/j.addr.2005.08.006. Epub 2005 Nov 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验